The paper presents the limited quantitative and qualitative analysis of the biotechnology and ICT industries in Lithuania and Estonia, as well as public policy instruments aimed at supporting the development of these industries. In depth analysis of the employment profile of the select biotechnology and ICT enterprises is provided. The paper suggests that existing public policy instruments designed to promote enterprise and innovation fail to differentiate among technological fields. This and other factors cause preference to the short cycle technological fields, such as ICT. Very few instruments are available for the needs of the biotechnology industry, and the long cycles and return horizons of biotechnology development are not recognized. These oversights are detrimental to the biotechnology sector and high-tech local employment. Suggestions on the policy reform are made.
Pisano G. P. (2006) Can science be a business? Lessons from biotech. Harvard Bus. Rev, 84(10): 114â€“125.
Binder G., Bashe P (2008) Science Lessons: What the Business of Biotech Taught Me About Management. Boston: Harvard Business Press.
Mets T. (2009) Creating Global Business Model for Knowledge-Intensive SMEs: The Small Transition Country Cases. Economics & Management, No. 14: 466-475.
Adomanis M. (2013) Estonia And The Department Of Meaningless Statistics. Forbes, 13 July, http://www.forbes.com/sites/markadomanis/2013/07/13/estonia-and-the-department-of-meaningless-statistics/, accessed 1 October 2013.
Kitsing M. (2013) Government as a Venture capitalist: Evidence from Estonia. Proceedings of the Industry Studies Association Annual Conference; 28-31 May 2013, http://www.industrystudies.pitt.edu/kansascity13/documents/Papers/3.4%20-%20Kitsing%20-%20Govt%20as%20Venture%20Capitalist.pdf, accessed 15 October 2013.
Ziegenbalg C., Munteanu O. (2011) Comprehensive analysis of programmes and initiatives in Estonia that assist the Collaboration between science and SME, http://mapeer-sme.eu/en/~/media/MaPEer-SME/DocumentLibrary/RTD%20programmes/ Estonia_programm_report, accessed 1 November 2013.
KiÅ¡kis M. (2012) Understanding Canadian Innovation System. Social Sciences, 75(1): 92-99.
Tassey G. (2013) Beyond the business cycle: The need for a technology-based growth strategy. Science and Public Policy, 40(3):293-315.
Melnikas B., JakubaviÄius A., Leichteris E., Vilys M (2011) Å½iniÅ³ ekonomikos kÅ«rimas: InovacijÅ³ paramos sistema. Vilnius: LIC.
Reiljan J., Paltser I. (2012) Estonian Innovation Policy Activity Against the Background of the EU Member States. Discussions on Estonian Economic Policy: Theory and Practice of Economic Policy, 20 (1): 147-164.
European Cooperation in Science and Technology 2014-2015 (2014) About COST: How to join a COST action, http://www.cost.eu/about_cost, accessed: 8 July 2014.
The Sixth Framework Programme in brief (2002) http://ec.europa.eu/research/fp6/pdf/fp6-in-brief_en.pdf, accessed 8 July 2014.
FP7 in Brief: How to get involved in the EU 7th Framework Programme for Research (2007) Luxembourg: Office for Official Publications of the European Communities, http://ec.europa.eu/research/fp7/pdf/fp7-inbrief_en.pdf, accessed 8 July 2014.
Communication from the Commission Europe 2020: A strategy for smart, sustainable and inclusive growth, http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2010:2020:FIN:EN:PDF, accessed 8 July 2014.
Horizon 2020 - The EU framework Programme for Research and Innovation, http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52011DC0808&from=EN, accessed 8 July 2014.
Estonian Biotechnology Programme (2009), http://www.eas.ee/images/doc/ettevotjale/innovatsioon/bio/btp_programmdok_2009_12_eng.pdf , accessed 8 July 2014.
Lithuanian 2011-2013 Industrial Biotechnology Development Programme (2011), http://www3.lrs.lt/pls/inter3/dokpaieska.showdoc_l?p_id=393692&p_query=&p_tr2=, accessed 8 July 2014.
MÃ¤nnik K., Miedzinski M., Reid A. (2011) Evaluation framework for innovation and enterprise support policies in Estonia. A report to the Ministry of Economic Affairs and Communications, Republic of Estonia, http://www.mkm.ee/public/Inno_17_24_11_2011.pdf, accessed 1 September 2013.
Revest V., Sapio A. (2012) Financing technology-based small firms in Europe: what do we know? Small Business Economics, 39(1): 179-205.
Feasibility study for an Estonian biotechnology programme, http://www.mkm.ee/public/inno_13.pdf, accessed 1 September 2013.
Suurna M. (2001) The developments in the business models of biotechnology in the Central and Eastern European countries: The example of Estonia. Journal of Commercial Biotechnology, Vol. 17: 84â€“108.
Biotechnology feasibility study in Lithuania (2007), http://www.smm.lt/uploads/documents/mokslas_bendradarbiavimasnacionalines/2_Biotechnologijos%20GS.pdf, accessed 1 September 2013.
Senker J., Enzing Ch., Reiss (2008) Biotechnology policies and performance in central and eastern Europe. International Journal of Biotechnology, 10 (4): 341-362.
Unless specified by prior arrangement, the author agrees to the following terms and assurances:
- For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
- I/we further give to the following assurances
- I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
- I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
- To the best of my/our knowledge, all the facts in the contribution are true and accurate;
- The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
- Nothing in the contribution is obscene or libellous;
- Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
- I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).